RU2757675C2 - Молекулы новых искусственных нуклеиновых кислот - Google Patents
Молекулы новых искусственных нуклеиновых кислот Download PDFInfo
- Publication number
- RU2757675C2 RU2757675C2 RU2017127203A RU2017127203A RU2757675C2 RU 2757675 C2 RU2757675 C2 RU 2757675C2 RU 2017127203 A RU2017127203 A RU 2017127203A RU 2017127203 A RU2017127203 A RU 2017127203A RU 2757675 C2 RU2757675 C2 RU 2757675C2
- Authority
- RU
- Russia
- Prior art keywords
- utr
- nucleic acid
- protein
- acid molecule
- sequence
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 420
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 325
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 325
- 108020005345 3' Untranslated Regions Proteins 0.000 claims abstract description 593
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 431
- 108020003589 5' Untranslated Regions Proteins 0.000 claims abstract description 417
- 108020004999 messenger RNA Proteins 0.000 claims abstract description 211
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 202
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 121
- 230000014616 translation Effects 0.000 claims abstract description 120
- 108700026244 Open Reading Frames Proteins 0.000 claims abstract description 99
- 230000014509 gene expression Effects 0.000 claims abstract description 79
- 238000013518 transcription Methods 0.000 claims abstract description 48
- 230000035897 transcription Effects 0.000 claims abstract description 48
- 238000000034 method Methods 0.000 claims abstract description 43
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 43
- 239000013598 vector Substances 0.000 claims abstract description 42
- 238000004519 manufacturing process Methods 0.000 claims abstract description 32
- 108091036066 Three prime untranslated region Proteins 0.000 claims abstract description 11
- 102100032610 Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Human genes 0.000 claims abstract 3
- 101001014590 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Proteins 0.000 claims abstract 3
- 101001014594 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms short Proteins 0.000 claims abstract 3
- 101001014610 Homo sapiens Neuroendocrine secretory protein 55 Proteins 0.000 claims abstract 3
- 101000797903 Homo sapiens Protein ALEX Proteins 0.000 claims abstract 3
- 239000002773 nucleotide Substances 0.000 claims description 122
- 125000003729 nucleotide group Chemical group 0.000 claims description 120
- -1 mu 1 Proteins 0.000 claims description 106
- 239000012634 fragment Substances 0.000 claims description 102
- 210000004027 cell Anatomy 0.000 claims description 98
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 63
- 101001115724 Homo sapiens MORN repeat-containing protein 2 Proteins 0.000 claims description 30
- 102100023291 MORN repeat-containing protein 2 Human genes 0.000 claims description 30
- 230000001965 increasing effect Effects 0.000 claims description 30
- 102100024326 Contactin-1 Human genes 0.000 claims description 22
- 102100023949 Cytochrome c oxidase subunit NDUFA4 Human genes 0.000 claims description 18
- 101001111225 Homo sapiens Cytochrome c oxidase subunit NDUFA4 Proteins 0.000 claims description 18
- 239000002299 complementary DNA Substances 0.000 claims description 18
- 101000727900 Homo sapiens ATP synthase subunit ATP5MJ, mitochondrial Proteins 0.000 claims description 17
- 210000004962 mammalian cell Anatomy 0.000 claims description 17
- 102100029772 ATP synthase subunit ATP5MJ, mitochondrial Human genes 0.000 claims description 16
- 108010070675 Glutathione transferase Proteins 0.000 claims description 16
- 101000909520 Homo sapiens Contactin-1 Proteins 0.000 claims description 16
- 101000601616 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 Proteins 0.000 claims description 16
- 102100037508 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 Human genes 0.000 claims description 16
- 238000001727 in vivo Methods 0.000 claims description 16
- 230000008488 polyadenylation Effects 0.000 claims description 16
- 102000005751 Alcohol Oxidoreductases Human genes 0.000 claims description 15
- 108010031132 Alcohol Oxidoreductases Proteins 0.000 claims description 15
- 101000906399 Homo sapiens Glutathione S-transferase Mu 4 Proteins 0.000 claims description 14
- 101000667295 Homo sapiens WASH complex subunit 3 Proteins 0.000 claims description 14
- 108091034057 RNA (poly(A)) Proteins 0.000 claims description 14
- 101001041661 Homo sapiens 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial Proteins 0.000 claims description 13
- 101001051835 Homo sapiens Mitochondrial pyruvate carrier 1 Proteins 0.000 claims description 13
- 101000929936 Homo sapiens Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 claims description 13
- 101000993070 Homo sapiens Calmodulin-lysine N-methyltransferase Proteins 0.000 claims description 12
- 101001071309 Homo sapiens GPI-anchor transamidase Proteins 0.000 claims description 12
- 101001082070 Homo sapiens Interferon alpha-inducible protein 6 Proteins 0.000 claims description 12
- 101001013097 Homo sapiens Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial Proteins 0.000 claims description 12
- 101000653592 Homo sapiens TBC1 domain family member 19 Proteins 0.000 claims description 12
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims description 12
- 102100039746 WASH complex subunit 3 Human genes 0.000 claims description 12
- 102100021403 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial Human genes 0.000 claims description 11
- 108010088751 Albumins Proteins 0.000 claims description 11
- 108700004605 Anaphase-Promoting Complex-Cyclosome Apc4 Subunit Proteins 0.000 claims description 11
- 102000052589 Anaphase-Promoting Complex-Cyclosome Apc4 Subunit Human genes 0.000 claims description 11
- 102100023523 Glutathione S-transferase Mu 4 Human genes 0.000 claims description 11
- 101000924461 Homo sapiens Annexin A4 Proteins 0.000 claims description 11
- 101000737584 Homo sapiens Cystathionine gamma-lyase Proteins 0.000 claims description 11
- 101000677891 Homo sapiens Iron-sulfur clusters transporter ABCB7, mitochondrial Proteins 0.000 claims description 11
- 101001111288 Homo sapiens NFU1 iron-sulfur cluster scaffold homolog, mitochondrial Proteins 0.000 claims description 11
- 101000851653 Homo sapiens Transmembrane protein 14A Proteins 0.000 claims description 11
- 101000743490 Homo sapiens V-set and immunoglobulin domain-containing protein 2 Proteins 0.000 claims description 11
- 102100024828 Mitochondrial pyruvate carrier 1 Human genes 0.000 claims description 11
- 102100035766 Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 claims description 11
- 101150001938 anapc4 gene Proteins 0.000 claims description 11
- 101150041050 ybx1 gene Proteins 0.000 claims description 11
- 101150009448 CPQ gene Proteins 0.000 claims description 10
- 102100031185 Calmodulin-lysine N-methyltransferase Human genes 0.000 claims description 10
- 102100036858 GPI-anchor transamidase Human genes 0.000 claims description 10
- 101000597680 Homo sapiens 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial Proteins 0.000 claims description 10
- 101000697700 Homo sapiens Bardet-Biedl syndrome 2 protein Proteins 0.000 claims description 10
- 102100027354 Interferon alpha-inducible protein 6 Human genes 0.000 claims description 10
- 102100029676 Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial Human genes 0.000 claims description 10
- 102100029852 TBC1 domain family member 19 Human genes 0.000 claims description 10
- 108010048626 Y-Box-Binding Protein 1 Proteins 0.000 claims description 10
- 102100022224 Y-box-binding protein 1 Human genes 0.000 claims description 10
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 101150019186 ATP5PO gene Proteins 0.000 claims description 9
- 102100034612 Annexin A4 Human genes 0.000 claims description 9
- 101150098502 Cox4i1 gene Proteins 0.000 claims description 9
- 101000757257 Homo sapiens Anoctamin-10 Proteins 0.000 claims description 9
- 101001117044 Homo sapiens Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A Proteins 0.000 claims description 9
- 101000860395 Homo sapiens Galactocerebrosidase Proteins 0.000 claims description 9
- 101000906394 Homo sapiens Glutathione S-transferase Mu 5 Proteins 0.000 claims description 9
- 101001010724 Homo sapiens Intraflagellar transport protein 88 homolog Proteins 0.000 claims description 9
- 101001004871 Homo sapiens Leucine-rich repeat-containing protein 28 Proteins 0.000 claims description 9
- 101000619898 Homo sapiens Leukotriene A-4 hydrolase Proteins 0.000 claims description 9
- 101000941071 Homo sapiens Lysosomal cobalamin transport escort protein LMBD1 Proteins 0.000 claims description 9
- 101001124017 Homo sapiens Nuclear transport factor 2 Proteins 0.000 claims description 9
- 101000871508 Homo sapiens PTB domain-containing engulfment adapter protein 1 Proteins 0.000 claims description 9
- 101000797874 Homo sapiens Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 Proteins 0.000 claims description 9
- 102100021504 Iron-sulfur clusters transporter ABCB7, mitochondrial Human genes 0.000 claims description 9
- 101150044934 NDUFS6 gene Proteins 0.000 claims description 9
- 102100024011 NFU1 iron-sulfur cluster scaffold homolog, mitochondrial Human genes 0.000 claims description 9
- 102100028418 Nuclear transport factor 2 Human genes 0.000 claims description 9
- 101150023029 PRDX4 gene Proteins 0.000 claims description 9
- 101150005696 TALDO1 gene Proteins 0.000 claims description 9
- 102100036796 Transmembrane protein 14A Human genes 0.000 claims description 9
- 101150025935 Tspo gene Proteins 0.000 claims description 9
- 238000000249 far-infrared magnetic resonance spectroscopy Methods 0.000 claims description 9
- 108010019813 leptin receptors Proteins 0.000 claims description 9
- 102100027883 Bardet-Biedl syndrome 2 protein Human genes 0.000 claims description 8
- 102100023524 Glutathione S-transferase Mu 5 Human genes 0.000 claims description 8
- 101001009252 Homo sapiens 2-hydroxyacyl-CoA lyase 1 Proteins 0.000 claims description 8
- 101000896020 Homo sapiens 3-hydroxyacyl-CoA dehydrogenase Proteins 0.000 claims description 8
- 101000841262 Homo sapiens 3-ketoacyl-CoA thiolase Proteins 0.000 claims description 8
- 101000769028 Homo sapiens ADP-ribosylation factor-like protein 6 Proteins 0.000 claims description 8
- 101000760704 Homo sapiens BRCA1-A complex subunit Abraxas 1 Proteins 0.000 claims description 8
- 101000737574 Homo sapiens Complement factor H Proteins 0.000 claims description 8
- 101000946505 Homo sapiens Cytosolic carboxypeptidase 1 Proteins 0.000 claims description 8
- 101000928786 Homo sapiens Di-N-acetylchitobiase Proteins 0.000 claims description 8
- 101001035145 Homo sapiens E3 ISG15-protein ligase HERC5 Proteins 0.000 claims description 8
- 101000920874 Homo sapiens Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial Proteins 0.000 claims description 8
- 101000925877 Homo sapiens Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 Proteins 0.000 claims description 8
- 101000906420 Homo sapiens Glucoside xylosyltransferase 2 Proteins 0.000 claims description 8
- 101001090483 Homo sapiens Glutathione S-transferase LANCL1 Proteins 0.000 claims description 8
- 101001009678 Homo sapiens Glycerol-3-phosphate dehydrogenase, mitochondrial Proteins 0.000 claims description 8
- 101000888229 Homo sapiens Glycine N-acyltransferase-like protein 2 Proteins 0.000 claims description 8
- 101000996225 Homo sapiens Glycine receptor subunit beta Proteins 0.000 claims description 8
- 101001021492 Homo sapiens HERV-H LTR-associating protein 3 Proteins 0.000 claims description 8
- 101001107782 Homo sapiens Iron-sulfur protein NUBPL Proteins 0.000 claims description 8
- 101001039669 Homo sapiens Lysophospholipid acyltransferase 5 Proteins 0.000 claims description 8
- 101000581533 Homo sapiens Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial Proteins 0.000 claims description 8
- 101000628796 Homo sapiens Microsomal glutathione S-transferase 2 Proteins 0.000 claims description 8
- 101000957333 Homo sapiens Muscleblind-like protein 3 Proteins 0.000 claims description 8
- 101001128623 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 Proteins 0.000 claims description 8
- 101000962058 Homo sapiens Neurobeachin-like protein 1 Proteins 0.000 claims description 8
- 101001128732 Homo sapiens Nucleoside diphosphate kinase 7 Proteins 0.000 claims description 8
- 101000691783 Homo sapiens Pirin Proteins 0.000 claims description 8
- 101000952078 Homo sapiens Probable ATP-dependent RNA helicase DDX60 Proteins 0.000 claims description 8
- 101001035144 Homo sapiens Probable E3 ubiquitin-protein ligase HERC6 Proteins 0.000 claims description 8
- 101000717815 Homo sapiens Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase Proteins 0.000 claims description 8
- 101001131748 Homo sapiens Quinone oxidoreductase Proteins 0.000 claims description 8
- 101000584785 Homo sapiens Ras-related protein Rab-7a Proteins 0.000 claims description 8
- 101000621061 Homo sapiens Serum paraoxonase/arylesterase 2 Proteins 0.000 claims description 8
- 101000703745 Homo sapiens Shootin-1 Proteins 0.000 claims description 8
- 101000648224 Homo sapiens Syntaxin-8 Proteins 0.000 claims description 8
- 101000801076 Homo sapiens TOM1-like protein 1 Proteins 0.000 claims description 8
- 101000698001 Homo sapiens Transcription initiation protein SPT3 homolog Proteins 0.000 claims description 8
- 102100025949 Leucine-rich repeat-containing protein 28 Human genes 0.000 claims description 8
- 102100022118 Leukotriene A-4 hydrolase Human genes 0.000 claims description 8
- 102100031335 Lysosomal cobalamin transport escort protein LMBD1 Human genes 0.000 claims description 8
- 101100393857 Mus musculus Gstm6 gene Proteins 0.000 claims description 8
- 101100182714 Mus musculus Ly6c1 gene Proteins 0.000 claims description 8
- 101150097980 PFDN5 gene Proteins 0.000 claims description 8
- 101150068820 bloc1s1 gene Proteins 0.000 claims description 8
- WVAKRQOMAINQPU-UHFFFAOYSA-N 2-[4-[2-[5-(2,2-dimethylbutyl)-1h-imidazol-2-yl]ethyl]phenyl]pyridine Chemical compound N1C(CC(C)(C)CC)=CN=C1CCC1=CC=C(C=2N=CC=CC=2)C=C1 WVAKRQOMAINQPU-UHFFFAOYSA-N 0.000 claims description 7
- 102100027324 2-hydroxyacyl-CoA lyase 1 Human genes 0.000 claims description 7
- 102100021834 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 claims description 7
- 102100029103 3-ketoacyl-CoA thiolase Human genes 0.000 claims description 7
- 102100028359 ADP-ribosylation factor-like protein 6 Human genes 0.000 claims description 7
- 101150060590 ANAPC5 gene Proteins 0.000 claims description 7
- 102000052588 Anaphase-Promoting Complex-Cyclosome Apc5 Subunit Human genes 0.000 claims description 7
- 108700004604 Anaphase-Promoting Complex-Cyclosome Apc5 Subunit Proteins 0.000 claims description 7
- 102100022989 Anoctamin-10 Human genes 0.000 claims description 7
- 101150033765 BAG1 gene Proteins 0.000 claims description 7
- 102100033787 CMP-sialic acid transporter Human genes 0.000 claims description 7
- 102100024316 Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A Human genes 0.000 claims description 7
- 102100035432 Complement factor H Human genes 0.000 claims description 7
- 102100035027 Cytosolic carboxypeptidase 1 Human genes 0.000 claims description 7
- 102100036495 Di-N-acetylchitobiase Human genes 0.000 claims description 7
- 102100031804 Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial Human genes 0.000 claims description 7
- 102100034236 Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 Human genes 0.000 claims description 7
- 102100028496 Galactocerebrosidase Human genes 0.000 claims description 7
- 102100034722 Glutathione S-transferase LANCL1 Human genes 0.000 claims description 7
- 102100030395 Glycerol-3-phosphate dehydrogenase, mitochondrial Human genes 0.000 claims description 7
- 102100039275 Glycine N-acyltransferase-like protein 2 Human genes 0.000 claims description 7
- 102100033958 Glycine receptor subunit beta Human genes 0.000 claims description 7
- 108700022944 Hemochromatosis Proteins 0.000 claims description 7
- 101150065637 Hfe gene Proteins 0.000 claims description 7
- 101000681020 Homo sapiens 2-iminobutanoate/2-iminopropanoate deaminase Proteins 0.000 claims description 7
- 101000783770 Homo sapiens ATP-binding cassette sub-family D member 3 Proteins 0.000 claims description 7
- 101001077066 Homo sapiens Adenylate kinase 9 Proteins 0.000 claims description 7
- 101000867778 Homo sapiens Calcium-dependent secretion activator 2 Proteins 0.000 claims description 7
- 101000910846 Homo sapiens Carboxypeptidase Q Proteins 0.000 claims description 7
- 101000868629 Homo sapiens Cell cycle progression protein 1 Proteins 0.000 claims description 7
- 101000952951 Homo sapiens Coatomer subunit gamma-2 Proteins 0.000 claims description 7
- 101000655234 Homo sapiens DNA-binding protein SATB1 Proteins 0.000 claims description 7
- 101000806152 Homo sapiens Dehydrogenase/reductase SDR family member 1 Proteins 0.000 claims description 7
- 101000776319 Homo sapiens Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase Proteins 0.000 claims description 7
- 101000896557 Homo sapiens Eukaryotic translation initiation factor 3 subunit B Proteins 0.000 claims description 7
- 101000595504 Homo sapiens GPI mannosyltransferase 3 Proteins 0.000 claims description 7
- 101000988834 Homo sapiens Hypoxanthine-guanine phosphoribosyltransferase Proteins 0.000 claims description 7
- 101000620894 Homo sapiens Lysophosphatidic acid phosphatase type 6 Proteins 0.000 claims description 7
- 101000616881 Homo sapiens MANSC domain-containing protein 1 Proteins 0.000 claims description 7
- 101000834125 Homo sapiens Medium-chain acyl-CoA ligase ACSF2, mitochondrial Proteins 0.000 claims description 7
- 101001057154 Homo sapiens Melanoma-associated antigen D2 Proteins 0.000 claims description 7
- 101001122313 Homo sapiens Metalloendopeptidase OMA1, mitochondrial Proteins 0.000 claims description 7
- 101000628785 Homo sapiens Microsomal glutathione S-transferase 3 Proteins 0.000 claims description 7
- 101000628925 Homo sapiens Mitochondrial intermediate peptidase Proteins 0.000 claims description 7
- 101000964177 Homo sapiens Mth938 domain-containing protein Proteins 0.000 claims description 7
- 101000721717 Homo sapiens NTF2-related export protein 2 Proteins 0.000 claims description 7
- 101001001487 Homo sapiens Phosphatidylinositol-glycan biosynthesis class F protein Proteins 0.000 claims description 7
- 101001137939 Homo sapiens Phosphorylase b kinase regulatory subunit beta Proteins 0.000 claims description 7
- 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 claims description 7
- 101001098989 Homo sapiens Propionyl-CoA carboxylase alpha chain, mitochondrial Proteins 0.000 claims description 7
- 101001098982 Homo sapiens Propionyl-CoA carboxylase beta chain, mitochondrial Proteins 0.000 claims description 7
- 101000595755 Homo sapiens TBC1 domain family member 8B Proteins 0.000 claims description 7
- 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 claims description 7
- 101000680132 Homo sapiens Trimeric intracellular cation channel type B Proteins 0.000 claims description 7
- 101000910952 Homo sapiens UPF0538 protein C2orf76 Proteins 0.000 claims description 7
- 101000667092 Homo sapiens Vacuolar protein sorting-associated protein 13A Proteins 0.000 claims description 7
- 101000747206 Homo sapiens tRNA pseudouridine synthase Pus10 Proteins 0.000 claims description 7
- 102100030007 Intraflagellar transport protein 88 homolog Human genes 0.000 claims description 7
- 102100021998 Iron-sulfur protein NUBPL Human genes 0.000 claims description 7
- 102100040944 Lysophospholipid acyltransferase 5 Human genes 0.000 claims description 7
- 102100026674 Medium-chain acyl-CoA ligase ACSF2, mitochondrial Human genes 0.000 claims description 7
- 102100027320 Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial Human genes 0.000 claims description 7
- 101100176800 Mus musculus Gstp2 gene Proteins 0.000 claims description 7
- 102100038751 Muscleblind-like protein 3 Human genes 0.000 claims description 7
- 102100032195 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 Human genes 0.000 claims description 7
- 102100031911 NEDD8 Human genes 0.000 claims description 7
- 101150107958 NEDD8 gene Proteins 0.000 claims description 7
- 102100039231 Neurobeachin-like protein 1 Human genes 0.000 claims description 7
- 102100032115 Nucleoside diphosphate kinase 7 Human genes 0.000 claims description 7
- 102100033719 PTB domain-containing engulfment adapter protein 1 Human genes 0.000 claims description 7
- 102100020854 Phosphorylase b kinase regulatory subunit beta Human genes 0.000 claims description 7
- 102100026123 Pirin Human genes 0.000 claims description 7
- 102100037439 Probable ATP-dependent RNA helicase DDX60 Human genes 0.000 claims description 7
- 102100039921 Probable E3 ubiquitin-protein ligase HERC6 Human genes 0.000 claims description 7
- 102100026610 Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase Human genes 0.000 claims description 7
- 102100033874 Probable sodium-coupled neutral amino acid transporter 6 Human genes 0.000 claims description 7
- 102100032337 Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 Human genes 0.000 claims description 7
- 102100034576 Quinone oxidoreductase Human genes 0.000 claims description 7
- 101150022627 RABAC1 gene Proteins 0.000 claims description 7
- 102100030019 Ras-related protein Rab-7a Human genes 0.000 claims description 7
- 108090000221 Ribosomal protein S6 Proteins 0.000 claims description 7
- 101150056859 S100a4 gene Proteins 0.000 claims description 7
- 108091006540 SLC35A1 Proteins 0.000 claims description 7
- 108091006935 SLC38A6 Proteins 0.000 claims description 7
- 108010019992 STAT4 Transcription Factor Proteins 0.000 claims description 7
- 102000005886 STAT4 Transcription Factor Human genes 0.000 claims description 7
- 102100022824 Serum paraoxonase/arylesterase 2 Human genes 0.000 claims description 7
- 102100031975 Shootin-1 Human genes 0.000 claims description 7
- 102100034803 Small nuclear ribonucleoprotein-associated protein N Human genes 0.000 claims description 7
- 102100028808 Syntaxin-8 Human genes 0.000 claims description 7
- 101150027764 TECR gene Proteins 0.000 claims description 7
- 102100033693 TOM1-like protein 1 Human genes 0.000 claims description 7
- 101710203399 Thiamin pyrophosphokinase 1 Proteins 0.000 claims description 7
- 102100037495 Thiamin pyrophosphokinase 1 Human genes 0.000 claims description 7
- 102100027912 Transcription initiation protein SPT3 homolog Human genes 0.000 claims description 7
- 101150105899 ppiB gene Proteins 0.000 claims description 7
- 108010039827 snRNP Core Proteins Proteins 0.000 claims description 7
- 101150062190 sod1 gene Proteins 0.000 claims description 7
- 229940035936 ubiquinone Drugs 0.000 claims description 7
- 102100022313 2-iminobutanoate/2-iminopropanoate deaminase Human genes 0.000 claims description 6
- 102100035315 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial Human genes 0.000 claims description 6
- MXCVHSXCXPHOLP-UHFFFAOYSA-N 4-oxo-6-propylchromene-2-carboxylic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=CC(CCC)=CC=C21 MXCVHSXCXPHOLP-UHFFFAOYSA-N 0.000 claims description 6
- 102100031012 60S ribosomal protein L36a-like Human genes 0.000 claims description 6
- 102100020973 ATP-binding cassette sub-family D member 3 Human genes 0.000 claims description 6
- 101150115549 ATP5PD gene Proteins 0.000 claims description 6
- 102100025153 Adenylate kinase 9 Human genes 0.000 claims description 6
- 102100024641 BRCA1-A complex subunit Abraxas 1 Human genes 0.000 claims description 6
- 101150018934 COX7B gene Proteins 0.000 claims description 6
- 101710134389 Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 Proteins 0.000 claims description 6
- 102100027667 Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 Human genes 0.000 claims description 6
- 102100026679 Carboxypeptidase Q Human genes 0.000 claims description 6
- 102100037291 Coatomer subunit gamma-2 Human genes 0.000 claims description 6
- 102100032881 DNA-binding protein SATB1 Human genes 0.000 claims description 6
- 101100235034 Danio rerio ldhba gene Proteins 0.000 claims description 6
- 102100037843 Dehydrogenase/reductase SDR family member 1 Human genes 0.000 claims description 6
- 102100032086 Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase Human genes 0.000 claims description 6
- 102100039922 E3 ISG15-protein ligase HERC5 Human genes 0.000 claims description 6
- 102100036080 GPI mannosyltransferase 3 Human genes 0.000 claims description 6
- 101150053089 GSTM1 gene Proteins 0.000 claims description 6
- 102100023528 Glucoside xylosyltransferase 2 Human genes 0.000 claims description 6
- 101150062487 Gstm5 gene Proteins 0.000 claims description 6
- 102100035944 HERV-H LTR-associating protein 3 Human genes 0.000 claims description 6
- 101000835276 Homo sapiens 3-ketoacyl-CoA thiolase, mitochondrial Proteins 0.000 claims description 6
- 101000604528 Homo sapiens 5'-nucleotidase domain-containing protein 1 Proteins 0.000 claims description 6
- 101001127258 Homo sapiens 60S ribosomal protein L36a-like Proteins 0.000 claims description 6
- 101000754209 Homo sapiens Actin-related protein 10 Proteins 0.000 claims description 6
- 101000761857 Homo sapiens BTB/POZ domain-containing protein 8 Proteins 0.000 claims description 6
- 101000766268 Homo sapiens Branched-chain-amino-acid aminotransferase, cytosolic Proteins 0.000 claims description 6
- 101000574820 Homo sapiens Calcium uptake protein 2, mitochondrial Proteins 0.000 claims description 6
- 101000912631 Homo sapiens Calmegin Proteins 0.000 claims description 6
- 101000934069 Homo sapiens Calpain-1 catalytic subunit Proteins 0.000 claims description 6
- 101000715398 Homo sapiens Caspase-1 Proteins 0.000 claims description 6
- 101000907994 Homo sapiens Cilia- and flagella-associated protein 36 Proteins 0.000 claims description 6
- 101000710917 Homo sapiens Citramalyl-CoA lyase, mitochondrial Proteins 0.000 claims description 6
- 101000748842 Homo sapiens Cytochrome c oxidase assembly protein COX11, mitochondrial Proteins 0.000 claims description 6
- 101001064250 Homo sapiens G-protein coupled receptor-associated protein LMBRD2 Proteins 0.000 claims description 6
- 101000857303 Homo sapiens Glomulin Proteins 0.000 claims description 6
- 101001075287 Homo sapiens Growth hormone receptor Proteins 0.000 claims description 6
- 101001044438 Homo sapiens Intraflagellar transport protein 52 homolog Proteins 0.000 claims description 6
- 101001010835 Homo sapiens Intraflagellar transport protein 74 homolog Proteins 0.000 claims description 6
- 101001006782 Homo sapiens Kinesin-associated protein 3 Proteins 0.000 claims description 6
- 101000601568 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 Proteins 0.000 claims description 6
- 101000595347 Homo sapiens Peroxisomal coenzyme A diphosphatase NUDT7 Proteins 0.000 claims description 6
- 101001002063 Homo sapiens Plasminogen receptor (KT) Proteins 0.000 claims description 6
- 101000875501 Homo sapiens Protein FAM114A2 Proteins 0.000 claims description 6
- 101001051723 Homo sapiens Ribosomal protein S6 kinase alpha-6 Proteins 0.000 claims description 6
- 101000724404 Homo sapiens Saccharopine dehydrogenase Proteins 0.000 claims description 6
- 101000831866 Homo sapiens Transmembrane protein 45A Proteins 0.000 claims description 6
- 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 claims description 6
- 102100022916 Lysophosphatidic acid phosphatase type 6 Human genes 0.000 claims description 6
- 102100021835 MANSC domain-containing protein 1 Human genes 0.000 claims description 6
- 102100027251 Melanoma-associated antigen D2 Human genes 0.000 claims description 6
- 102100027104 Metalloendopeptidase OMA1, mitochondrial Human genes 0.000 claims description 6
- 102100026723 Microsomal glutathione S-transferase 2 Human genes 0.000 claims description 6
- 102100026722 Microsomal glutathione S-transferase 3 Human genes 0.000 claims description 6
- 102100026934 Mitochondrial intermediate peptidase Human genes 0.000 claims description 6
- 102100040358 Mth938 domain-containing protein Human genes 0.000 claims description 6
- 101150065592 NME2 gene Proteins 0.000 claims description 6
- 102100025112 NTF2-related export protein 2 Human genes 0.000 claims description 6
- 102100039022 Propionyl-CoA carboxylase alpha chain, mitochondrial Human genes 0.000 claims description 6
- 102100039025 Propionyl-CoA carboxylase beta chain, mitochondrial Human genes 0.000 claims description 6
- 101150054830 S100A6 gene Proteins 0.000 claims description 6
- 101150005828 SWI5 gene Proteins 0.000 claims description 6
- 102100036054 TBC1 domain family member 8B Human genes 0.000 claims description 6
- 102100024324 Toll-like receptor 3 Human genes 0.000 claims description 6
- 102100022234 Trimeric intracellular cation channel type B Human genes 0.000 claims description 6
- 102100039114 Vacuolar protein sorting-associated protein 13A Human genes 0.000 claims description 6
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical class N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 6
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 6
- 101150100271 ldhb gene Proteins 0.000 claims description 6
- 102100039155 tRNA pseudouridine synthase Pus10 Human genes 0.000 claims description 6
- 102100026105 3-ketoacyl-CoA thiolase, mitochondrial Human genes 0.000 claims description 5
- 102100038684 5'-nucleotidase domain-containing protein 1 Human genes 0.000 claims description 5
- 102100025753 AP2-interacting clathrin-endocytosis protein Human genes 0.000 claims description 5
- 102100021581 Actin-related protein 10 Human genes 0.000 claims description 5
- 102100025523 Calcium uptake protein 2, mitochondrial Human genes 0.000 claims description 5
- 102100032583 Calcium-dependent secretion activator 2 Human genes 0.000 claims description 5
- 102100026092 Calmegin Human genes 0.000 claims description 5
- 102100025172 Calpain-1 catalytic subunit Human genes 0.000 claims description 5
- 102100032346 Cell cycle progression protein 1 Human genes 0.000 claims description 5
- 102100023329 Cilia- and flagella-associated protein 36 Human genes 0.000 claims description 5
- 102100034229 Citramalyl-CoA lyase, mitochondrial Human genes 0.000 claims description 5
- 101150032052 Cox6a1 gene Proteins 0.000 claims description 5
- 101150073289 Cox6b1 gene Proteins 0.000 claims description 5
- 102100041024 Cytochrome c oxidase assembly protein COX11, mitochondrial Human genes 0.000 claims description 5
- 102100030656 G-protein coupled receptor-associated protein LMBRD2 Human genes 0.000 claims description 5
- 102100025894 Glomulin Human genes 0.000 claims description 5
- 101150050733 Gnas gene Proteins 0.000 claims description 5
- 102100020948 Growth hormone receptor Human genes 0.000 claims description 5
- 101000929676 Homo sapiens ATP-binding cassette sub-family A member 6 Proteins 0.000 claims description 5
- 101000961406 Homo sapiens Calcium uniporter regulatory subunit MCUb, mitochondrial Proteins 0.000 claims description 5
- 101000599612 Homo sapiens Peroxisomal carnitine O-octanoyltransferase Proteins 0.000 claims description 5
- 101000932816 Homo sapiens Uncharacterized protein C1orf112 Proteins 0.000 claims description 5
- 102100022470 Intraflagellar transport protein 52 homolog Human genes 0.000 claims description 5
- 102100029997 Intraflagellar transport protein 74 homolog Human genes 0.000 claims description 5
- 102100027930 Kinesin-associated protein 3 Human genes 0.000 claims description 5
- 101150036157 Nenf gene Proteins 0.000 claims description 5
- 101150096217 PHYH gene Proteins 0.000 claims description 5
- 102100036024 Peroxisomal coenzyme A diphosphatase NUDT7 Human genes 0.000 claims description 5
- 102100039421 Phytanoyl-CoA dioxygenase, peroxisomal Human genes 0.000 claims description 5
- 102100035194 Placenta growth factor Human genes 0.000 claims description 5
- 102100035967 Plasminogen receptor (KT) Human genes 0.000 claims description 5
- 102100035993 Protein FAM114A2 Human genes 0.000 claims description 5
- 102100024897 Ribosomal protein S6 kinase alpha-6 Human genes 0.000 claims description 5
- 102100028294 Saccharopine dehydrogenase Human genes 0.000 claims description 5
- 101150075013 Tmsb10 gene Proteins 0.000 claims description 5
- 102100024186 Transmembrane protein 45A Human genes 0.000 claims description 5
- 101150025179 UBA52 gene Proteins 0.000 claims description 5
- 102100026670 UPF0538 protein C2orf76 Human genes 0.000 claims description 5
- 101150021490 mrpl23 gene Proteins 0.000 claims description 5
- 102100036612 ATP-binding cassette sub-family A member 6 Human genes 0.000 claims description 4
- 101150069123 Atp5mk gene Proteins 0.000 claims description 4
- 102100026437 Branched-chain-amino-acid aminotransferase, cytosolic Human genes 0.000 claims description 4
- 102100039372 Calcium uniporter regulatory subunit MCUb, mitochondrial Human genes 0.000 claims description 4
- 102100035904 Caspase-1 Human genes 0.000 claims description 4
- 101150076793 Cox8a gene Proteins 0.000 claims description 4
- 101100200593 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) rps19 gene Proteins 0.000 claims description 4
- 101000633708 Homo sapiens Src kinase-associated phosphoprotein 2 Proteins 0.000 claims description 4
- 108010066789 Lymphocyte Antigen 96 Proteins 0.000 claims description 4
- 102000018671 Lymphocyte Antigen 96 Human genes 0.000 claims description 4
- 102100037524 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 Human genes 0.000 claims description 4
- 101150071263 PARK7 gene Proteins 0.000 claims description 4
- 102100037974 Peroxisomal carnitine O-octanoyltransferase Human genes 0.000 claims description 4
- 101150027061 RPS16 gene Proteins 0.000 claims description 4
- 101100418504 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rps1601 gene Proteins 0.000 claims description 4
- 101150036293 Selenop gene Proteins 0.000 claims description 4
- 102100025478 Uncharacterized protein C1orf112 Human genes 0.000 claims description 4
- 101150116648 rpsP gene Proteins 0.000 claims description 4
- 101000633169 Homo sapiens Sorting nexin-14 Proteins 0.000 claims description 3
- 102100029213 Src kinase-associated phosphoprotein 2 Human genes 0.000 claims description 3
- 102000004346 ribosomal protein L9 Human genes 0.000 claims description 3
- 108090000907 ribosomal protein L9 Proteins 0.000 claims description 3
- 101710088194 Dehydrogenase Proteins 0.000 claims description 2
- 102100029598 Sorting nexin-14 Human genes 0.000 claims description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims 3
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims 3
- 101150007921 CBR2 gene Proteins 0.000 claims 2
- 108091035707 Consensus sequence Proteins 0.000 claims 2
- 102100036534 Glutathione S-transferase Mu 1 Human genes 0.000 claims 2
- 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 claims 2
- 108010033040 Histones Proteins 0.000 claims 2
- 101001071694 Homo sapiens Glutathione S-transferase Mu 1 Proteins 0.000 claims 2
- 102100033714 40S ribosomal protein S6 Human genes 0.000 claims 1
- 102100035429 Cystathionine gamma-lyase Human genes 0.000 claims 1
- 102100022283 Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial Human genes 0.000 claims 1
- 102100024827 Dynamin-1-like protein Human genes 0.000 claims 1
- 102000048988 Hemochromatosis Human genes 0.000 claims 1
- 101000836407 Homo sapiens 4-trimethylaminobutyraldehyde dehydrogenase Proteins 0.000 claims 1
- 101000755868 Homo sapiens Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial Proteins 0.000 claims 1
- 101000909218 Homo sapiens Dynamin-1-like protein Proteins 0.000 claims 1
- 101000872514 Homo sapiens Probable E3 ubiquitin-protein ligase HERC1 Proteins 0.000 claims 1
- 102100029825 Leptin receptor gene-related protein Human genes 0.000 claims 1
- 108010086428 NADH Dehydrogenase Proteins 0.000 claims 1
- 102000006746 NADH Dehydrogenase Human genes 0.000 claims 1
- 101100381300 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) atp-5 gene Proteins 0.000 claims 1
- 102100034747 Probable E3 ubiquitin-protein ligase HERC1 Human genes 0.000 claims 1
- 108020005202 Viral DNA Proteins 0.000 claims 1
- 108091014756 nucleotide binding proteins Proteins 0.000 claims 1
- 102000026415 nucleotide binding proteins Human genes 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 14
- 239000000126 substance Substances 0.000 abstract description 3
- 235000018102 proteins Nutrition 0.000 description 172
- 102000036639 antigens Human genes 0.000 description 45
- 108091007433 antigens Proteins 0.000 description 45
- 239000000427 antigen Substances 0.000 description 43
- 238000013519 translation Methods 0.000 description 43
- 238000001890 transfection Methods 0.000 description 40
- 102000008013 Electron Transport Complex I Human genes 0.000 description 35
- 108010089760 Electron Transport Complex I Proteins 0.000 description 35
- 108020004414 DNA Proteins 0.000 description 34
- 241000282414 Homo sapiens Species 0.000 description 31
- 150000001413 amino acids Chemical group 0.000 description 24
- 230000006870 function Effects 0.000 description 22
- 244000052769 pathogen Species 0.000 description 22
- 241000699666 Mus <mouse, genus> Species 0.000 description 21
- 230000008569 process Effects 0.000 description 18
- 229940024606 amino acid Drugs 0.000 description 17
- 235000001014 amino acid Nutrition 0.000 description 17
- 238000001415 gene therapy Methods 0.000 description 17
- 238000011239 genetic vaccination Methods 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 17
- 230000028993 immune response Effects 0.000 description 16
- 108060001084 Luciferase Proteins 0.000 description 15
- 102000002278 Ribosomal Proteins Human genes 0.000 description 15
- 108010000605 Ribosomal Proteins Proteins 0.000 description 15
- 238000006731 degradation reaction Methods 0.000 description 15
- 230000010076 replication Effects 0.000 description 15
- 108091006027 G proteins Proteins 0.000 description 14
- 102000034286 G proteins Human genes 0.000 description 14
- 102000005720 Glutathione transferase Human genes 0.000 description 14
- 108091027974 Mature messenger RNA Proteins 0.000 description 14
- 230000032823 cell division Effects 0.000 description 14
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 229960005486 vaccine Drugs 0.000 description 14
- 230000019522 cellular metabolic process Effects 0.000 description 13
- 230000004048 modification Effects 0.000 description 13
- 238000012986 modification Methods 0.000 description 13
- 239000000178 monomer Substances 0.000 description 13
- 230000001717 pathogenic effect Effects 0.000 description 13
- 108020004705 Codon Proteins 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 108010052285 Membrane Proteins Proteins 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 210000000987 immune system Anatomy 0.000 description 12
- 230000002163 immunogen Effects 0.000 description 12
- 230000003308 immunostimulating effect Effects 0.000 description 12
- 230000004936 stimulating effect Effects 0.000 description 12
- 108700039887 Essential Genes Proteins 0.000 description 11
- 210000001744 T-lymphocyte Anatomy 0.000 description 11
- 230000033289 adaptive immune response Effects 0.000 description 11
- 230000015556 catabolic process Effects 0.000 description 11
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 10
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 10
- 241000699660 Mus musculus Species 0.000 description 10
- 210000005006 adaptive immune system Anatomy 0.000 description 10
- 239000002671 adjuvant Substances 0.000 description 10
- 238000002372 labelling Methods 0.000 description 10
- 108010087195 Contactin 1 Proteins 0.000 description 9
- 239000005089 Luciferase Substances 0.000 description 9
- 108091081024 Start codon Proteins 0.000 description 9
- 101150114197 TOP gene Proteins 0.000 description 9
- 230000001939 inductive effect Effects 0.000 description 9
- 230000015788 innate immune response Effects 0.000 description 9
- 230000035800 maturation Effects 0.000 description 9
- 230000035772 mutation Effects 0.000 description 9
- 230000009145 protein modification Effects 0.000 description 9
- 239000002719 pyrimidine nucleotide Substances 0.000 description 9
- 150000003230 pyrimidines Chemical class 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 101150096470 Atp5f1e gene Proteins 0.000 description 8
- 102100031775 Leptin receptor Human genes 0.000 description 8
- 238000007792 addition Methods 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 230000000087 stabilizing effect Effects 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 101000954716 Homo sapiens Cytoplasmic dynein 2 light intermediate chain 1 Proteins 0.000 description 7
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 description 7
- 101000838236 Homo sapiens T-complex protein 11-like protein 2 Proteins 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 7
- 102100038295 V-set and immunoglobulin domain-containing protein 2 Human genes 0.000 description 7
- 230000033228 biological regulation Effects 0.000 description 7
- 125000002091 cationic group Chemical group 0.000 description 7
- 238000010367 cloning Methods 0.000 description 7
- 210000005260 human cell Anatomy 0.000 description 7
- 230000002035 prolonged effect Effects 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 101100155198 Caenorhabditis elegans ubl-5 gene Proteins 0.000 description 6
- 102100037064 Cytoplasmic dynein 2 light intermediate chain 1 Human genes 0.000 description 6
- 101710205374 Extracellular elastase Proteins 0.000 description 6
- 102100031180 Hereditary hemochromatosis protein Human genes 0.000 description 6
- 101000598552 Homo sapiens Acetyl-CoA acetyltransferase, mitochondrial Proteins 0.000 description 6
- 101001076319 Homo sapiens Interleukin-1 receptor-associated kinase 1-binding protein 1 Proteins 0.000 description 6
- 101000617830 Homo sapiens Sterol O-acyltransferase 1 Proteins 0.000 description 6
- 101000852716 Homo sapiens T-cell immunomodulatory protein Proteins 0.000 description 6
- 101000743430 Homo sapiens Vacuolar protein sorting-associated protein 8 homolog Proteins 0.000 description 6
- 101000988412 Homo sapiens cGMP-specific 3',5'-cyclic phosphodiesterase Proteins 0.000 description 6
- 102100032816 Integrin alpha-6 Human genes 0.000 description 6
- 102000003861 Ribosomal protein S6 Human genes 0.000 description 6
- 102100023843 Selenoprotein P Human genes 0.000 description 6
- 102100028608 T-complex protein 11-like protein 2 Human genes 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
- 102000018146 globin Human genes 0.000 description 6
- 108060003196 globin Proteins 0.000 description 6
- 210000005007 innate immune system Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 101150038502 ALDH2 gene Proteins 0.000 description 5
- 108010025454 Cyclin-Dependent Kinase 5 Proteins 0.000 description 5
- 102100026805 Cyclin-dependent-like kinase 5 Human genes 0.000 description 5
- 108091005902 Hemoglobin subunit alpha Proteins 0.000 description 5
- 101000777764 Homo sapiens Cyclin-dependent kinase-like 2 Proteins 0.000 description 5
- 101000728245 Homo sapiens Protein Aster-C Proteins 0.000 description 5
- 101000836084 Homo sapiens Serpin B7 Proteins 0.000 description 5
- 101000638274 Homo sapiens Type 2 DNA topoisomerase 6 subunit B-like Proteins 0.000 description 5
- 102100025957 Interleukin-1 receptor-associated kinase 1-binding protein 1 Human genes 0.000 description 5
- 101100393855 Mus musculus Gstm5 gene Proteins 0.000 description 5
- 102100021993 Sterol O-acyltransferase 1 Human genes 0.000 description 5
- 102100036378 T-cell immunomodulatory protein Human genes 0.000 description 5
- 102000002689 Toll-like receptor Human genes 0.000 description 5
- 108020000411 Toll-like receptor Proteins 0.000 description 5
- 102100038324 Vacuolar protein sorting-associated protein 8 homolog Human genes 0.000 description 5
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 150000003838 adenosines Chemical class 0.000 description 5
- 210000003719 b-lymphocyte Anatomy 0.000 description 5
- 102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- 210000002540 macrophage Anatomy 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 5
- 102100031571 40S ribosomal protein S16 Human genes 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 102100031685 Cyclin-dependent kinase-like 2 Human genes 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 4
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 4
- 101150016456 Hexa gene Proteins 0.000 description 4
- 101000897063 Homo sapiens Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 Proteins 0.000 description 4
- 101000835086 Homo sapiens Transferrin receptor protein 2 Proteins 0.000 description 4
- 108091092195 Intron Proteins 0.000 description 4
- 101150058224 MIF gene Proteins 0.000 description 4
- 101150064183 MYL6 gene Proteins 0.000 description 4
- 101150027754 Map1lc3a gene Proteins 0.000 description 4
- 102000018697 Membrane Proteins Human genes 0.000 description 4
- 108090000143 Mouse Proteins Proteins 0.000 description 4
- 101150002585 OAZ1 gene Proteins 0.000 description 4
- 102100029804 Protein Aster-C Human genes 0.000 description 4
- 101150081636 RPS13 gene Proteins 0.000 description 4
- 108700008625 Reporter Genes Proteins 0.000 description 4
- 101150004811 Rps4x gene Proteins 0.000 description 4
- 102100025521 Serpin B7 Human genes 0.000 description 4
- 102100032084 Type 2 DNA topoisomerase 6 subunit B-like Human genes 0.000 description 4
- 108091023045 Untranslated Region Proteins 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 210000004443 dendritic cell Anatomy 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 108010092955 ribosomal protein S16 Proteins 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- 101100511868 Caenorhabditis elegans lsm-4 gene Proteins 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 101150077445 Ecm1 gene Proteins 0.000 description 3
- 102100021962 Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 Human genes 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- 108060002716 Exonuclease Proteins 0.000 description 3
- 101150041639 GPX4 gene Proteins 0.000 description 3
- 102100027685 Hemoglobin subunit alpha Human genes 0.000 description 3
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 3
- 101000625846 Homo sapiens TBC domain-containing protein kinase-like protein Proteins 0.000 description 3
- 108091006905 Human Serum Albumin Proteins 0.000 description 3
- 101100046602 Mus musculus Tomm6 gene Proteins 0.000 description 3
- 108091036407 Polyadenylation Proteins 0.000 description 3
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 3
- 101150042469 SSR4 gene Proteins 0.000 description 3
- 230000024932 T cell mediated immunity Effects 0.000 description 3
- 108700009124 Transcription Initiation Site Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 230000007969 cellular immunity Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 102000013165 exonuclease Human genes 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 230000028996 humoral immune response Effects 0.000 description 3
- 230000004727 humoral immunity Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000012976 mRNA stabilization Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000015654 memory Effects 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 108010019441 polyphosphoinositide phosphatase Proteins 0.000 description 3
- 230000009711 regulatory function Effects 0.000 description 3
- 210000003705 ribosome Anatomy 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- QCWBIPKYTBFWHH-FDDDBJFASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-ethynylpyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C#C)=C1 QCWBIPKYTBFWHH-FDDDBJFASA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
- 102100035916 60S ribosomal protein L11 Human genes 0.000 description 2
- 102100025643 60S ribosomal protein L12 Human genes 0.000 description 2
- 102100026926 60S ribosomal protein L4 Human genes 0.000 description 2
- 102100035841 60S ribosomal protein L7 Human genes 0.000 description 2
- 102100036630 60S ribosomal protein L7a Human genes 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- 108010083359 Antigen Receptors Proteins 0.000 description 2
- 241000219194 Arabidopsis Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- 102100038547 FSD1-like protein Human genes 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- 101000853617 Homo sapiens 60S ribosomal protein L7 Proteins 0.000 description 2
- 101000853243 Homo sapiens 60S ribosomal protein L7a Proteins 0.000 description 2
- 101000757370 Homo sapiens Anaphase-promoting complex subunit 4 Proteins 0.000 description 2
- 101000725947 Homo sapiens Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 Proteins 0.000 description 2
- 101001030528 Homo sapiens FSD1-like protein Proteins 0.000 description 2
- 101001129927 Homo sapiens Leptin receptor Proteins 0.000 description 2
- 101000684181 Homo sapiens Selenoprotein P Proteins 0.000 description 2
- 101000821500 Homo sapiens Sterol carrier protein 2 Proteins 0.000 description 2
- 101000643636 Homo sapiens Synaptonemal complex protein 2 Proteins 0.000 description 2
- 101000763579 Homo sapiens Toll-like receptor 1 Proteins 0.000 description 2
- 101000763537 Homo sapiens Toll-like receptor 10 Proteins 0.000 description 2
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 2
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 2
- 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 description 2
- 101000669406 Homo sapiens Toll-like receptor 6 Proteins 0.000 description 2
- 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 2
- 101000800483 Homo sapiens Toll-like receptor 8 Proteins 0.000 description 2
- 101000713575 Homo sapiens Tubulin beta-3 chain Proteins 0.000 description 2
- 102000003839 Human Proteins Human genes 0.000 description 2
- 108090000144 Human Proteins Proteins 0.000 description 2
- 102100030703 Interleukin-22 Human genes 0.000 description 2
- 102000003939 Membrane transport proteins Human genes 0.000 description 2
- 108090000301 Membrane transport proteins Proteins 0.000 description 2
- 101100380627 Mus musculus Atp5f1e gene Proteins 0.000 description 2
- 101100436435 Mus musculus Atp5me gene Proteins 0.000 description 2
- 101100110359 Mus musculus Atp5mj gene Proteins 0.000 description 2
- 101100381299 Mus musculus Atp5po gene Proteins 0.000 description 2
- 101100326174 Mus musculus Bloc1s1 gene Proteins 0.000 description 2
- 101100112477 Mus musculus Cbr2 gene Proteins 0.000 description 2
- 101100497397 Mus musculus Cops9 gene Proteins 0.000 description 2
- 101100221703 Mus musculus Cox4i1 gene Proteins 0.000 description 2
- 101100166334 Mus musculus Cpq gene Proteins 0.000 description 2
- 101100283979 Mus musculus Gstm1 gene Proteins 0.000 description 2
- 101100457041 Mus musculus Mgst3 gene Proteins 0.000 description 2
- 101100404481 Mus musculus Ndufa4 gene Proteins 0.000 description 2
- 101100516313 Mus musculus Ndufs5 gene Proteins 0.000 description 2
- 101100293910 Mus musculus Ndufs6 gene Proteins 0.000 description 2
- 101100202471 Mus musculus Sec61b gene Proteins 0.000 description 2
- 101100149690 Mus musculus Snrpd2 gene Proteins 0.000 description 2
- 101100098715 Mus musculus Taldo1 gene Proteins 0.000 description 2
- 101100481579 Mus musculus Tlr11 gene Proteins 0.000 description 2
- 101100481580 Mus musculus Tlr12 gene Proteins 0.000 description 2
- 101100371176 Mus musculus Tspo gene Proteins 0.000 description 2
- 101100431662 Mus musculus Ybx1 gene Proteins 0.000 description 2
- 102100031789 Myeloid-derived growth factor Human genes 0.000 description 2
- 102000007079 Peptide Fragments Human genes 0.000 description 2
- 108010033276 Peptide Fragments Proteins 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- 101100393859 Rattus norvegicus Gstm7 gene Proteins 0.000 description 2
- 108020001027 Ribosomal DNA Proteins 0.000 description 2
- 102000004285 Ribosomal Protein L3 Human genes 0.000 description 2
- 108090000894 Ribosomal Protein L3 Proteins 0.000 description 2
- 102000013817 Ribosomal protein L13 Human genes 0.000 description 2
- 108050003655 Ribosomal protein L13 Proteins 0.000 description 2
- 102000004209 Ribosomal protein L5 Human genes 0.000 description 2
- 108090000776 Ribosomal protein L5 Proteins 0.000 description 2
- 102100029453 T-cell receptor-associated transmembrane adapter 1 Human genes 0.000 description 2
- 102100024750 TBC domain-containing protein kinase-like protein Human genes 0.000 description 2
- 210000000447 Th1 cell Anatomy 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 2
- 102100027010 Toll-like receptor 1 Human genes 0.000 description 2
- 102100027009 Toll-like receptor 10 Human genes 0.000 description 2
- 102100024333 Toll-like receptor 2 Human genes 0.000 description 2
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 2
- 102100039357 Toll-like receptor 5 Human genes 0.000 description 2
- 102100039387 Toll-like receptor 6 Human genes 0.000 description 2
- 102100039390 Toll-like receptor 7 Human genes 0.000 description 2
- 102100033110 Toll-like receptor 8 Human genes 0.000 description 2
- 102100033117 Toll-like receptor 9 Human genes 0.000 description 2
- 108010023649 Tripartite Motif Proteins Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 101150044494 Uqcrq gene Proteins 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003172 anti-dna Effects 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 210000000612 antigen-presenting cell Anatomy 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 210000003162 effector t lymphocyte Anatomy 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 102000034238 globular proteins Human genes 0.000 description 2
- 108091005896 globular proteins Proteins 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 229940029575 guanosine Drugs 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 238000001638 lipofection Methods 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 210000003563 lymphoid tissue Anatomy 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 101150025474 mecr gene Proteins 0.000 description 2
- 230000021121 meiosis Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 101150040063 orf gene Proteins 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000029983 protein stabilization Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108010025552 ribosomal protein L11 Proteins 0.000 description 2
- 108090000893 ribosomal protein L4 Proteins 0.000 description 2
- 102000004291 ribosomal protein L6 Human genes 0.000 description 2
- 108090000892 ribosomal protein L6 Proteins 0.000 description 2
- 108010037046 ribosomal protein L7-L12 Proteins 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000003827 upregulation Effects 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- GRJDAVSXJPWJNJ-RCYBNZJXSA-N 1-[(2r,3r,4s,5s)-5-[bromo(hydroxy)methyl]-3,4-dihydroxyoxolan-2-yl]pyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](C(Br)O)O[C@H]1N1C(=O)NC(=O)C=C1 GRJDAVSXJPWJNJ-RCYBNZJXSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- KHWCHTKSEGGWEX-RRKCRQDMSA-N 2'-deoxyadenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 KHWCHTKSEGGWEX-RRKCRQDMSA-N 0.000 description 1
- NCMVOABPESMRCP-SHYZEUOFSA-N 2'-deoxycytosine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 NCMVOABPESMRCP-SHYZEUOFSA-N 0.000 description 1
- LTFMZDNNPPEQNG-KVQBGUIXSA-N 2'-deoxyguanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 LTFMZDNNPPEQNG-KVQBGUIXSA-N 0.000 description 1
- ZLOIGESWDJYCTF-UHFFFAOYSA-N 4-Thiouridine Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-UHFFFAOYSA-N 0.000 description 1
- LZINOQJQXIEBNN-UHFFFAOYSA-N 4-hydroxybutyl dihydrogen phosphate Chemical compound OCCCCOP(O)(O)=O LZINOQJQXIEBNN-UHFFFAOYSA-N 0.000 description 1
- ZLOIGESWDJYCTF-XVFCMESISA-N 4-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-XVFCMESISA-N 0.000 description 1
- AGFIRQJZCNVMCW-UAKXSSHOSA-N 5-bromouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 AGFIRQJZCNVMCW-UAKXSSHOSA-N 0.000 description 1
- XYVLZAYJHCECPN-UHFFFAOYSA-L 6-aminohexyl phosphate Chemical compound NCCCCCCOP([O-])([O-])=O XYVLZAYJHCECPN-UHFFFAOYSA-L 0.000 description 1
- 102100021308 60S ribosomal protein L23 Human genes 0.000 description 1
- 102100040768 60S ribosomal protein L32 Human genes 0.000 description 1
- 102100041029 60S ribosomal protein L9 Human genes 0.000 description 1
- 102100028777 AP-1 complex subunit sigma-1A Human genes 0.000 description 1
- 102100020970 ATP-binding cassette sub-family D member 2 Human genes 0.000 description 1
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102100022734 Acyl carrier protein, mitochondrial Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 102000006306 Antigen Receptors Human genes 0.000 description 1
- 101100166427 Arabidopsis thaliana CCD4 gene Proteins 0.000 description 1
- 101100339677 Arabidopsis thaliana HRS1 gene Proteins 0.000 description 1
- 101100516627 Arabidopsis thaliana NIFU5 gene Proteins 0.000 description 1
- 101100029748 Arabidopsis thaliana PHYD gene Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 102100035606 Beta-casein Human genes 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 108010029697 CD40 Ligand Proteins 0.000 description 1
- 102100032937 CD40 ligand Human genes 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 101100337167 Crocus sativus GLT3 gene Proteins 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 101150115404 GSTM2 gene Proteins 0.000 description 1
- 101150032248 Gpx6 gene Proteins 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 101150001766 Gstm4 gene Proteins 0.000 description 1
- 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
- 101000656896 Homo sapiens 40S ribosomal protein S6 Proteins 0.000 description 1
- 101000770593 Homo sapiens 5-demethoxyubiquinone hydroxylase, mitochondrial Proteins 0.000 description 1
- 101000672886 Homo sapiens 60S ribosomal protein L9 Proteins 0.000 description 1
- 101000768000 Homo sapiens AP-1 complex subunit sigma-1A Proteins 0.000 description 1
- 101000783774 Homo sapiens ATP-binding cassette sub-family D member 2 Proteins 0.000 description 1
- 101100110358 Homo sapiens ATP5MJ gene Proteins 0.000 description 1
- 101000678845 Homo sapiens Acyl carrier protein, mitochondrial Proteins 0.000 description 1
- 101000947120 Homo sapiens Beta-casein Proteins 0.000 description 1
- 101000640779 Homo sapiens CMP-sialic acid transporter Proteins 0.000 description 1
- 101000911965 Homo sapiens Cyclin-dependent-like kinase 5 Proteins 0.000 description 1
- 101001002470 Homo sapiens Interferon lambda-1 Proteins 0.000 description 1
- 101000853002 Homo sapiens Interleukin-25 Proteins 0.000 description 1
- 101000853000 Homo sapiens Interleukin-26 Proteins 0.000 description 1
- 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 description 1
- 101000999365 Homo sapiens Intraflagellar transport-associated protein Proteins 0.000 description 1
- 101001090713 Homo sapiens L-lactate dehydrogenase A chain Proteins 0.000 description 1
- 101000611240 Homo sapiens Low molecular weight phosphotyrosine protein phosphatase Proteins 0.000 description 1
- 101001018020 Homo sapiens Lymphocyte antigen 96 Proteins 0.000 description 1
- 101001128431 Homo sapiens Myeloid-derived growth factor Proteins 0.000 description 1
- 101000783960 Homo sapiens N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase Proteins 0.000 description 1
- 101000604411 Homo sapiens NADH-ubiquinone oxidoreductase chain 1 Proteins 0.000 description 1
- 101000578287 Homo sapiens Non-POU domain-containing octamer-binding protein Proteins 0.000 description 1
- 101000741800 Homo sapiens Peptidyl-prolyl cis-trans isomerase H Proteins 0.000 description 1
- 101000595489 Homo sapiens Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Proteins 0.000 description 1
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 1
- 101000609253 Homo sapiens Phytanoyl-CoA dioxygenase, peroxisomal Proteins 0.000 description 1
- 101000640842 Homo sapiens Probable sodium-coupled neutral amino acid transporter 6 Proteins 0.000 description 1
- 101000826368 Homo sapiens Signal transducer and activator of transcription 4 Proteins 0.000 description 1
- 101000657580 Homo sapiens Small nuclear ribonucleoprotein-associated protein N Proteins 0.000 description 1
- 101000662765 Homo sapiens Thiamin pyrophosphokinase 1 Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 102100026720 Interferon beta Human genes 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000003814 Interleukin-10 Human genes 0.000 description 1
- 108090000174 Interleukin-10 Proteins 0.000 description 1
- 108090000177 Interleukin-11 Proteins 0.000 description 1
- 102000003815 Interleukin-11 Human genes 0.000 description 1
- 108010065805 Interleukin-12 Proteins 0.000 description 1
- 102000013462 Interleukin-12 Human genes 0.000 description 1
- 108090000172 Interleukin-15 Proteins 0.000 description 1
- 102000013691 Interleukin-17 Human genes 0.000 description 1
- 108050003558 Interleukin-17 Proteins 0.000 description 1
- 102000003810 Interleukin-18 Human genes 0.000 description 1
- 108090000171 Interleukin-18 Proteins 0.000 description 1
- 102100039879 Interleukin-19 Human genes 0.000 description 1
- 108050009288 Interleukin-19 Proteins 0.000 description 1
- 102100020873 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000013264 Interleukin-23 Human genes 0.000 description 1
- 108010065637 Interleukin-23 Proteins 0.000 description 1
- 102100036679 Interleukin-26 Human genes 0.000 description 1
- 108010066979 Interleukin-27 Proteins 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 102000000646 Interleukin-3 Human genes 0.000 description 1
- 102100021596 Interleukin-31 Human genes 0.000 description 1
- 101710181613 Interleukin-31 Proteins 0.000 description 1
- 102100033501 Interleukin-32 Human genes 0.000 description 1
- 108010067003 Interleukin-33 Proteins 0.000 description 1
- 102000017761 Interleukin-33 Human genes 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 102000004388 Interleukin-4 Human genes 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- 102000000743 Interleukin-5 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 102100021592 Interleukin-7 Human genes 0.000 description 1
- 108010002586 Interleukin-7 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 102000004890 Interleukin-8 Human genes 0.000 description 1
- 108010002335 Interleukin-9 Proteins 0.000 description 1
- 102000000585 Interleukin-9 Human genes 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102100034671 L-lactate dehydrogenase A chain Human genes 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108090000362 Lymphotoxin-beta Proteins 0.000 description 1
- 102100026894 Lymphotoxin-beta Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 102000043129 MHC class I family Human genes 0.000 description 1
- 108091054437 MHC class I family Proteins 0.000 description 1
- 108091054438 MHC class II family Proteins 0.000 description 1
- 102000013967 Monokines Human genes 0.000 description 1
- 108010050619 Monokines Proteins 0.000 description 1
- 101001002800 Mus musculus 14 kDa phosphohistidine phosphatase Proteins 0.000 description 1
- 101100055261 Mus musculus Aldh2 gene Proteins 0.000 description 1
- 101100109082 Mus musculus Anapc13 gene Proteins 0.000 description 1
- 101100216243 Mus musculus Anapc5 gene Proteins 0.000 description 1
- 101100435997 Mus musculus Arpc3 gene Proteins 0.000 description 1
- 101100003262 Mus musculus Atp5mg gene Proteins 0.000 description 1
- 101100437077 Mus musculus Atp5mk gene Proteins 0.000 description 1
- 101100436430 Mus musculus Atp5pd gene Proteins 0.000 description 1
- 101100111190 Mus musculus Bag1 gene Proteins 0.000 description 1
- 101100058109 Mus musculus Bcap31 gene Proteins 0.000 description 1
- 101100168960 Mus musculus Cox6a1 gene Proteins 0.000 description 1
- 101100497606 Mus musculus Cox6b1 gene Proteins 0.000 description 1
- 101100440796 Mus musculus Cox7b gene Proteins 0.000 description 1
- 101100114588 Mus musculus Cox8a gene Proteins 0.000 description 1
- 101100388632 Mus musculus Ecm1 gene Proteins 0.000 description 1
- 101100501709 Mus musculus Ergic3 gene Proteins 0.000 description 1
- 101100236308 Mus musculus Gaa gene Proteins 0.000 description 1
- 101100162405 Mus musculus Gnas gene Proteins 0.000 description 1
- 101100015722 Mus musculus Gpx4 gene Proteins 0.000 description 1
- 101100393849 Mus musculus Gstm3 gene Proteins 0.000 description 1
- 101100177570 Mus musculus Hexa gene Proteins 0.000 description 1
- 101100284916 Mus musculus Higd2a gene Proteins 0.000 description 1
- 101100455657 Mus musculus Lamtor2 gene Proteins 0.000 description 1
- 101100181469 Mus musculus Ldhb gene Proteins 0.000 description 1
- 101100511872 Mus musculus Lsm4 gene Proteins 0.000 description 1
- 101001018878 Mus musculus Macrophage migration inhibitory factor Proteins 0.000 description 1
- 101100345702 Mus musculus Map1lc3a gene Proteins 0.000 description 1
- 101100423707 Mus musculus Mars2 gene Proteins 0.000 description 1
- 101100290649 Mus musculus Mecr gene Proteins 0.000 description 1
- 101100077717 Mus musculus Morn2 gene Proteins 0.000 description 1
- 101100305460 Mus musculus Mrpl23 gene Proteins 0.000 description 1
- 101100402841 Mus musculus Mtch1 gene Proteins 0.000 description 1
- 101100079051 Mus musculus Myl6 gene Proteins 0.000 description 1
- 101000636770 Mus musculus NEDD8 Proteins 0.000 description 1
- 101100516274 Mus musculus Ndufa1 gene Proteins 0.000 description 1
- 101100460095 Mus musculus Ndufa13 gene Proteins 0.000 description 1
- 101100404464 Mus musculus Ndufa2 gene Proteins 0.000 description 1
- 101100404471 Mus musculus Ndufa3 gene Proteins 0.000 description 1
- 101100348320 Mus musculus Ndufa7 gene Proteins 0.000 description 1
- 101100404492 Mus musculus Ndufb11 gene Proteins 0.000 description 1
- 101100516299 Mus musculus Ndufb7 gene Proteins 0.000 description 1
- 101100293894 Mus musculus Ndufb8 gene Proteins 0.000 description 1
- 101100460155 Mus musculus Nenf gene Proteins 0.000 description 1
- 101100404389 Mus musculus Nme2 gene Proteins 0.000 description 1
- 101100188449 Mus musculus Oaz1 gene Proteins 0.000 description 1
- 101100028685 Mus musculus Park7 gene Proteins 0.000 description 1
- 101100519975 Mus musculus Pcbd2 gene Proteins 0.000 description 1
- 101100519653 Mus musculus Pfdn5 gene Proteins 0.000 description 1
- 101100353009 Mus musculus Ppib gene Proteins 0.000 description 1
- 101100191312 Mus musculus Prdx4 gene Proteins 0.000 description 1
- 101100464982 Mus musculus Rabac1 gene Proteins 0.000 description 1
- 101100305992 Mus musculus Romo1 gene Proteins 0.000 description 1
- 101100420488 Mus musculus S100a4 gene Proteins 0.000 description 1
- 101100476471 Mus musculus S100a6 gene Proteins 0.000 description 1
- 101100202484 Mus musculus Sec61g gene Proteins 0.000 description 1
- 101100421229 Mus musculus Selenop gene Proteins 0.000 description 1
- 101100421197 Mus musculus Sem1 gene Proteins 0.000 description 1
- 101100310096 Mus musculus Serf1 gene Proteins 0.000 description 1
- 101100203373 Mus musculus Slpi gene Proteins 0.000 description 1
- 101100094819 Mus musculus Snrpg gene Proteins 0.000 description 1
- 101100366159 Mus musculus Sod1 gene Proteins 0.000 description 1
- 101100204066 Mus musculus Ssr4 gene Proteins 0.000 description 1
- 101100045697 Mus musculus Tecr gene Proteins 0.000 description 1
- 101100481581 Mus musculus Tlr13 gene Proteins 0.000 description 1
- 101100046388 Mus musculus Tmem160 gene Proteins 0.000 description 1
- 101100047928 Mus musculus Tmsb10 gene Proteins 0.000 description 1
- 101100046671 Mus musculus Trappc6a gene Proteins 0.000 description 1
- 101100155204 Mus musculus Ubl5 gene Proteins 0.000 description 1
- 101100355309 Mus musculus Uqcr11 gene Proteins 0.000 description 1
- 101100086095 Mus musculus Uqcrq gene Proteins 0.000 description 1
- 102100038625 NADH-ubiquinone oxidoreductase chain 1 Human genes 0.000 description 1
- 101150014378 NDUFA5 gene Proteins 0.000 description 1
- 102000012064 NLR Proteins Human genes 0.000 description 1
- 108091005686 NOD-like receptors Proteins 0.000 description 1
- 102100028102 Non-POU domain-containing octamer-binding protein Human genes 0.000 description 1
- 108700022034 Opsonin Proteins Proteins 0.000 description 1
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- 102100038827 Peptidyl-prolyl cis-trans isomerase H Human genes 0.000 description 1
- 102100036050 Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Human genes 0.000 description 1
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 1
- 108091005685 RIG-I-like receptors Proteins 0.000 description 1
- 230000021839 RNA stabilization Effects 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 102000004282 Ribosomal protein S9 Human genes 0.000 description 1
- 108090000878 Ribosomal protein S9 Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 101100129874 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PGD1 gene Proteins 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 101100129591 Schizosaccharomyces pombe (strain 972 / ATCC 24843) mcp6 gene Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 210000004241 Th2 cell Anatomy 0.000 description 1
- 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
- 230000006154 adenylylation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000009824 affinity maturation Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 description 1
- 101150087698 alpha gene Proteins 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000010516 arginylation Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940031567 attenuated vaccine Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000013602 bacteriophage vector Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 230000006242 butyrylation Effects 0.000 description 1
- 238000010514 butyrylation reaction Methods 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000006790 cellular biosynthetic process Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 231100000005 chromosome aberration Toxicity 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 1
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000006126 farnesylation Effects 0.000 description 1
- 125000004072 flavinyl group Chemical group 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 231100000221 frame shift mutation induction Toxicity 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 230000006251 gamma-carboxylation Effects 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000006127 geranylation Effects 0.000 description 1
- 230000012178 germinal center formation Effects 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical compound OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- PHNWGDTYCJFUGZ-UHFFFAOYSA-L hexyl phosphate Chemical compound CCCCCCOP([O-])([O-])=O PHNWGDTYCJFUGZ-UHFFFAOYSA-L 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 101150115593 ifc-2 gene Proteins 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000000677 immunologic agent Substances 0.000 description 1
- 229940124541 immunological agent Drugs 0.000 description 1
- 230000006054 immunological memory Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 102000004114 interleukin 20 Human genes 0.000 description 1
- 108090000681 interleukin 20 Proteins 0.000 description 1
- 108010074108 interleukin-21 Proteins 0.000 description 1
- 108010074109 interleukin-22 Proteins 0.000 description 1
- 102000003898 interleukin-24 Human genes 0.000 description 1
- 108090000237 interleukin-24 Proteins 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 230000006122 isoprenylation Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000006144 lipoylation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004726 long-term protective immunity Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000005210 lymphoid organ Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000034701 macropinocytosis Effects 0.000 description 1
- 230000017538 malonylation Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 230000009061 membrane transport Effects 0.000 description 1
- 210000001806 memory b lymphocyte Anatomy 0.000 description 1
- 210000003071 memory t lymphocyte Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 230000007498 myristoylation Effects 0.000 description 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000026792 palmitoylation Effects 0.000 description 1
- 101150029755 park gene Proteins 0.000 description 1
- 230000004963 pathophysiological condition Effects 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 150000008298 phosphoramidates Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000001884 polyglutamylation Effects 0.000 description 1
- 230000019474 polyglycylation Effects 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000013823 prenylation Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000002213 purine nucleotide Substances 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000037425 regulation of transcription Effects 0.000 description 1
- 230000009712 regulation of translation Effects 0.000 description 1
- 108010025325 ribosomal protein L32 Proteins 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 102000035025 signaling receptors Human genes 0.000 description 1
- 108091005475 signaling receptors Proteins 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000037439 somatic mutation Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000035322 succinylation Effects 0.000 description 1
- 238000010613 succinylation reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000005451 thionucleotide Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/68—Stabilisation of the vector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0066—Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/10—Vectors comprising a special translation-regulating system regulates levels of translation
- C12N2840/105—Vectors comprising a special translation-regulating system regulates levels of translation enhancing translation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Evolutionary Biology (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2014003479 | 2014-12-30 | ||
| EPPCT/EP2014/003479 | 2014-12-30 | ||
| PCT/EP2015/081366 WO2016107877A1 (en) | 2014-12-30 | 2015-12-29 | Artificial nucleic acid molecules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017127203A RU2017127203A (ru) | 2019-02-01 |
| RU2017127203A3 RU2017127203A3 (OSRAM) | 2020-01-10 |
| RU2757675C2 true RU2757675C2 (ru) | 2021-10-20 |
Family
ID=52814040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017127203A RU2757675C2 (ru) | 2014-12-30 | 2015-12-29 | Молекулы новых искусственных нуклеиновых кислот |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20180148727A1 (OSRAM) |
| EP (2) | EP3240558A1 (OSRAM) |
| JP (2) | JP6907116B2 (OSRAM) |
| KR (1) | KR102580696B1 (OSRAM) |
| CN (1) | CN107124889A (OSRAM) |
| AU (1) | AU2015373404B2 (OSRAM) |
| BR (1) | BR112017009835A2 (OSRAM) |
| CA (1) | CA2966092A1 (OSRAM) |
| MX (1) | MX2017008670A (OSRAM) |
| RU (1) | RU2757675C2 (OSRAM) |
| SG (2) | SG11201704681QA (OSRAM) |
| WO (1) | WO2016107877A1 (OSRAM) |
Families Citing this family (142)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10347710B4 (de) | 2003-10-14 | 2006-03-30 | Johannes-Gutenberg-Universität Mainz | Rekombinante Impfstoffe und deren Verwendung |
| DE102005046490A1 (de) | 2005-09-28 | 2007-03-29 | Johannes-Gutenberg-Universität Mainz | Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen |
| WO2012019630A1 (en) | 2010-08-13 | 2012-02-16 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein |
| WO2012116714A1 (en) | 2011-03-02 | 2012-09-07 | Curevac Gmbh | Vaccination in elderly patients |
| LT3473267T (lt) | 2011-05-24 | 2021-11-25 | BioNTech SE | Individualizuotos vakcinos nuo vėžio |
| WO2013120497A1 (en) | 2012-02-15 | 2013-08-22 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein |
| WO2013120499A1 (en) | 2012-02-15 | 2013-08-22 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen |
| WO2013143555A1 (en) | 2012-03-26 | 2013-10-03 | Biontech Ag | Rna formulation for immunotherapy |
| RU2750261C2 (ru) | 2012-03-27 | 2021-06-25 | Кьюрвак Аг | Искусственные молекулы нуклеиновых кислот для улучшенной экспрессии белков и пептидов |
| US10155031B2 (en) | 2012-11-28 | 2018-12-18 | Biontech Rna Pharmaceuticals Gmbh | Individualized vaccines for cancer |
| SG10201710472PA (en) | 2013-02-22 | 2018-02-27 | Curevac Ag | Combination of vaccination and inhibition of the pd-1 pathway |
| WO2014180490A1 (en) | 2013-05-10 | 2014-11-13 | Biontech Ag | Predicting immunogenicity of t cell epitopes |
| RU2712743C2 (ru) | 2013-08-21 | 2020-01-30 | Куревак Аг | Вакцина против бешенства |
| CA2915728A1 (en) | 2013-08-21 | 2015-02-26 | Thomas Kramps | Respiratory syncytial virus (rsv) vaccine |
| CN105473157A (zh) | 2013-08-21 | 2016-04-06 | 库瑞瓦格股份公司 | 组合疫苗 |
| CA2925021C (en) | 2013-11-01 | 2025-05-06 | Curevac Ag | MODIFIED MESSENGER RIBONUCLE ACID (MRNA) WITH REDUCED IMMUNOSTIMULATING PROPERTIES |
| WO2015101416A1 (en) | 2013-12-30 | 2015-07-09 | Curevac Gmbh | Methods for rna analysis |
| JP6584414B2 (ja) | 2013-12-30 | 2019-10-02 | キュアバック アーゲー | 人工核酸分子 |
| US10307472B2 (en) | 2014-03-12 | 2019-06-04 | Curevac Ag | Combination of vaccination and OX40 agonists |
| US10369216B2 (en) | 2014-04-01 | 2019-08-06 | Curevac Ag | Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant |
| ES2727776T3 (es) | 2014-06-10 | 2019-10-18 | Curevac Ag | Método para mejorar la producción de ARN |
| CN106795096B (zh) | 2014-06-25 | 2020-05-29 | 爱康泰生治疗公司 | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 |
| WO2016045732A1 (en) | 2014-09-25 | 2016-03-31 | Biontech Rna Pharmaceuticals Gmbh | Stable formulations of lipids and liposomes |
| EP3230458B1 (en) | 2014-12-12 | 2020-02-19 | CureVac AG | Artificial nucleic acid molecules for improved protein expression |
| WO2016128060A1 (en) | 2015-02-12 | 2016-08-18 | Biontech Ag | Predicting t cell epitopes useful for vaccination |
| EP3283059B1 (en) | 2015-04-13 | 2024-01-03 | CureVac Manufacturing GmbH | Method for producing rna compositions |
| WO2016165831A1 (en) | 2015-04-17 | 2016-10-20 | Curevac Ag | Lyophilization of rna |
| EP3289083A4 (en) | 2015-04-27 | 2018-12-19 | The Trustees Of The University Of Pennsylvania | Nucleoside-modified rna for inducing an adaptive immune response |
| SG11201708867UA (en) | 2015-04-30 | 2017-11-29 | Curevac Ag | Immobilized poly(n)polymerase |
| WO2016180430A1 (en) | 2015-05-08 | 2016-11-17 | Curevac Ag | Method for producing rna |
| GB201508025D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Fabry disease gene therapy |
| ES2875589T3 (es) | 2015-05-15 | 2021-11-10 | Curevac Ag | Regímenes de sensibilización-refuerzo que implican la administración de al menos un constructo de ARNm |
| CN107635587A (zh) | 2015-05-20 | 2018-01-26 | 库瑞瓦格股份公司 | 包含长链rna的干燥粉末组合物 |
| EP3928800A3 (en) | 2015-05-20 | 2022-03-23 | CureVac AG | Dry powder composition comprising long-chain rna |
| EP3303575B1 (en) | 2015-05-29 | 2022-03-16 | CureVac AG | Method for adding cap structures to rna using immobilized enzymes |
| PL4108769T3 (pl) | 2015-05-29 | 2024-02-05 | CureVac Manufacturing GmbH | Sposób wytwarzania i oczyszczania rna obejmujący co najmniej jeden etap filtracji o przepływie stycznym |
| HRP20240865T1 (hr) | 2015-06-29 | 2024-10-11 | Acuitas Therapeutics Inc. | Lipidi i formulacije lipidnih nanočestica za isporuku nukleinskih kiselina |
| US10501768B2 (en) | 2015-07-13 | 2019-12-10 | Curevac Ag | Method of producing RNA from circular DNA and corresponding template DNA |
| KR102645398B1 (ko) | 2015-08-28 | 2024-03-07 | 큐어백 에스이 | 신규 인공 핵산 분자 |
| CN105112552B (zh) * | 2015-09-28 | 2018-02-27 | 北京泱深生物信息技术有限公司 | Ift52基因在骨质疏松症诊断中的应用 |
| WO2017059902A1 (en) | 2015-10-07 | 2017-04-13 | Biontech Rna Pharmaceuticals Gmbh | 3' utr sequences for stabilization of rna |
| EP3362576A1 (en) | 2015-10-12 | 2018-08-22 | CureVac AG | Automated method for isolation, selection and/or detection of microorganisms or cells comprised in a solution |
| AU2016343803B2 (en) | 2015-10-28 | 2021-04-29 | Acuitas Therapeutics, Inc. | Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| WO2017081110A1 (en) | 2015-11-09 | 2017-05-18 | Curevac Ag | Rotavirus vaccines |
| EP3701963A1 (en) | 2015-12-22 | 2020-09-02 | CureVac AG | Method for producing rna molecule compositions |
| WO2017109161A1 (en) | 2015-12-23 | 2017-06-29 | Curevac Ag | Method of rna in vitro transcription using a buffer containing a dicarboxylic acid or tricarboxylic acid or a salt thereof |
| US11723967B2 (en) | 2016-02-17 | 2023-08-15 | CureVac SE | Zika virus vaccine |
| EP3423595A1 (en) | 2016-03-03 | 2019-01-09 | CureVac AG | Rna analysis by total hydrolysis |
| WO2017186928A1 (en) | 2016-04-29 | 2017-11-02 | Curevac Ag | Rna encoding an antibody |
| EP3452101A2 (en) | 2016-05-04 | 2019-03-13 | CureVac AG | Rna encoding a therapeutic protein |
| EP4477662A3 (en) | 2016-05-04 | 2025-03-19 | CureVac SE | Nucleic acid molecules and uses thereof |
| EP3468613A1 (en) | 2016-06-09 | 2019-04-17 | CureVac AG | Hybrid carriers for nucleic acid cargo |
| WO2018013525A1 (en) | 2016-07-11 | 2018-01-18 | Translate Bio Ma, Inc. | Nucleic acid conjugates and uses thereof |
| US20190185859A1 (en) | 2016-08-19 | 2019-06-20 | Curevac Ag | Rna for cancer therapy |
| US12491261B2 (en) | 2016-10-26 | 2025-12-09 | Acuitas Therapeutics, Inc. | Lipid nanoparticle formulations |
| WO2018096179A1 (en) | 2016-11-28 | 2018-05-31 | Curevac Ag | Method for purifying rna |
| JP2019535839A (ja) | 2016-11-29 | 2019-12-12 | ピュアテック ヘルス エルエルシー | 治療剤の送達のためのエクソソーム |
| WO2018104540A1 (en) | 2016-12-08 | 2018-06-14 | Curevac Ag | Rnas for wound healing |
| EP3551230A1 (en) * | 2016-12-08 | 2019-10-16 | CureVac AG | Rna for treatment or prophylaxis of a liver disease |
| WO2018115527A2 (en) | 2016-12-23 | 2018-06-28 | Curevac Ag | Mers coronavirus vaccine |
| EP3558354A1 (en) | 2016-12-23 | 2019-10-30 | CureVac AG | Lassa virus vaccine |
| EP3558355A2 (en) | 2016-12-23 | 2019-10-30 | CureVac AG | Henipavirus vaccine |
| BR112019014314A2 (pt) | 2017-01-11 | 2020-02-18 | The Trustees Of The University Of Pennsylvania | Composição, e, método de indução de uma resposta imune adaptativa contra vírus zika. |
| CA3050614A1 (en) | 2017-03-17 | 2018-09-20 | Curevac Ag | Rna vaccine and immune checkpoint inhibitors for combined anticancer therapy |
| JP2020513824A (ja) | 2017-03-24 | 2020-05-21 | キュアバック アーゲー | Ｃｒｉｓｐｒ関連タンパク質をコードする核酸、及びその使用 |
| WO2018191657A1 (en) | 2017-04-13 | 2018-10-18 | Acuitas Therapeutics, Inc. | Lipids for delivery of active agents |
| JP7464954B2 (ja) | 2017-04-27 | 2024-04-10 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Ｃ型肝炎ウイルスに対するヌクレオシド修飾ｍＲＮＡ－脂質ナノ粒子系統ワクチン |
| EP4410317A3 (en) | 2017-04-28 | 2024-10-30 | Acuitas Therapeutics Inc. | Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| WO2018211038A1 (en) | 2017-05-17 | 2018-11-22 | Curevac Ag | Method for determining at least one quality parameter of an rna sample |
| WO2018224166A1 (en) | 2017-06-09 | 2018-12-13 | Biontech Rna Pharmaceuticals Gmbh | Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy |
| EP4494652A3 (en) | 2017-07-04 | 2025-05-14 | CureVac SE | Cancer rna-vaccine |
| WO2019036008A1 (en) | 2017-08-16 | 2019-02-21 | Acuitas Therapeutics, Inc. | LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS |
| US11542225B2 (en) | 2017-08-17 | 2023-01-03 | Acuitas Therapeutics, Inc. | Lipids for use in lipid nanoparticle formulations |
| EP3668834B1 (en) | 2017-08-17 | 2024-10-02 | Acuitas Therapeutics, Inc. | Lipids for use in lipid nanoparticle formulations |
| WO2019036030A1 (en) | 2017-08-17 | 2019-02-21 | Acuitas Therapeutics, Inc. | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS |
| US11602557B2 (en) | 2017-08-22 | 2023-03-14 | Cure Vac SE | Bunyavirales vaccine |
| RU2020115287A (ru) * | 2017-10-19 | 2021-11-19 | Куревак Аг | Новые молекулы искусственных нуклеиновых кислот |
| US11692002B2 (en) | 2017-11-08 | 2023-07-04 | CureVac SE | RNA sequence adaptation |
| EP3723796A1 (en) | 2017-12-13 | 2020-10-21 | CureVac AG | Flavivirus vaccine |
| WO2019121803A1 (en) * | 2017-12-21 | 2019-06-27 | Baseclick Gmbh | Click-modified mrna |
| EP3728634A1 (en) | 2017-12-21 | 2020-10-28 | CureVac AG | Linear double stranded dna coupled to a single support or a tag and methods for producing said linear double stranded dna |
| CN109985230B (zh) * | 2018-01-02 | 2023-10-17 | 上海普佑生物医药有限公司 | 一种蛋白在制备预防和治疗肾病药物中的应用 |
| WO2019140102A1 (en) | 2018-01-10 | 2019-07-18 | Translate Bio Ma, Inc. | Compositions and methods for facilitating delivery of synthetic nucleic acids to cells |
| WO2019193183A2 (en) | 2018-04-05 | 2019-10-10 | Curevac Ag | Novel yellow fever nucleic acid molecules for vaccination |
| EP4227319B1 (en) | 2018-04-17 | 2025-11-26 | CureVac SE | Novel rsv rna molecules and compositions for vaccination |
| CN119685309A (zh) * | 2018-05-25 | 2025-03-25 | 柏业公司 | 用于预防和治疗纤维化相关疾病和呼吸系统疾病的双调蛋白基因特异性双链寡核苷酸和包含其的组合物 |
| EP3813874A1 (en) | 2018-06-27 | 2021-05-05 | CureVac AG | Novel lassa virus rna molecules and compositions for vaccination |
| KR20210027368A (ko) | 2018-06-28 | 2021-03-10 | 큐어백 아게 | 알엔에이 시험관 내 전사를 위한 바이오리액터 |
| CN110699367B (zh) * | 2018-07-09 | 2021-06-11 | 武汉纽福斯生物科技有限公司 | 编码人nadh脱氢酶亚单位4蛋白的核酸及其应用 |
| IL322436A (en) | 2018-09-21 | 2025-09-01 | Acuitas Therapeutics Inc | Systems and methods for producing lipid nanoparticles and liposomes |
| JP7532360B2 (ja) * | 2018-11-16 | 2024-08-13 | エンコーデッド セラピューティクス， インコーポレイテッド | ウィルソン病を処置するための組成物および方法 |
| SG11202106666UA (en) | 2018-12-21 | 2021-07-29 | Curevac Ag | Methods for rna analysis |
| AU2019410737A1 (en) | 2018-12-21 | 2021-06-10 | CureVac SE | RNA for malaria vaccines |
| CA3125511A1 (en) | 2019-02-08 | 2020-08-13 | Curevac Ag | Coding rna administered into the suprachoroidal space in the treatment of ophthalmic diseases |
| EP3986452A1 (en) | 2019-06-18 | 2022-04-27 | CureVac AG | Rotavirus mrna vaccine |
| CA3144902A1 (en) | 2019-08-14 | 2022-01-19 | Andreas Thess | Rna combinations and compositions with decreased immunostimulatory properties |
| JP2022546417A (ja) * | 2019-08-29 | 2022-11-04 | チューリッヒ大学 | 最小ｍＲＮＡおよびその使用 |
| CN114599789A (zh) * | 2019-10-17 | 2022-06-07 | 公立大学法人名古屋市立大学 | 人工合成mRNA及其利用 |
| US11241493B2 (en) | 2020-02-04 | 2022-02-08 | Curevac Ag | Coronavirus vaccine |
| CA3160511A1 (en) | 2020-02-04 | 2021-08-12 | Susanne RAUCH | Coronavirus vaccine |
| US12194089B2 (en) | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
| CA3170740A1 (en) | 2020-05-29 | 2021-12-02 | Curevac Ag | Nucleic acid based combination vaccines |
| FI4182297T3 (fi) | 2020-07-16 | 2025-12-05 | Acuitas Therapeutics Inc | Kationisia lipidejä käytettäväksi lipidinanohiukkasissa |
| EP4172194A1 (en) | 2020-07-31 | 2023-05-03 | CureVac SE | Nucleic acid encoded antibody mixtures |
| EP4157344A2 (en) | 2020-08-31 | 2023-04-05 | CureVac SE | Multivalent nucleic acid based coronavirus vaccines |
| CA3205569A1 (en) | 2020-12-22 | 2022-06-30 | CureVac SE | Rna vaccine against sars-cov-2 variants |
| WO2022135993A2 (en) | 2020-12-22 | 2022-06-30 | Curevac Ag | Pharmaceutical composition comprising lipid-based carriers encapsulating rna for multidose administration |
| WO2022137133A1 (en) | 2020-12-22 | 2022-06-30 | Curevac Ag | Rna vaccine against sars-cov-2 variants |
| CN114717230B (zh) * | 2021-01-05 | 2024-09-03 | 麦塞拿治疗(香港)有限公司 | 成纤维细胞生长因子mRNA的无细胞和无载体体外RNA转录方法和核酸分子 |
| US20240102065A1 (en) | 2021-01-27 | 2024-03-28 | CureVac SE | Method of reducing the immunostimulatory properties of in vitro transcribed rna |
| AU2022220704A1 (en) | 2021-02-12 | 2022-08-18 | Alnylam Pharmaceuticals, Inc. | Superoxide dismutase 1 (sod1) irna compositions and methods of use thereof for treating or preventing superoxide dismutase 1- (sod1-) associated neurodegenerative diseases |
| JP2024511206A (ja) | 2021-03-26 | 2024-03-12 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
| WO2022207862A2 (en) | 2021-03-31 | 2022-10-06 | Curevac Ag | Syringes containing pharmaceutical compositions comprising rna |
| WO2022233880A1 (en) | 2021-05-03 | 2022-11-10 | Curevac Ag | Improved nucleic acid sequence for cell type specific expression |
| WO2022256597A1 (en) | 2021-06-04 | 2022-12-08 | Translate Bio, Inc. | Assay for quantitative assessment of mrna capping efficiency |
| CN115448982B (zh) * | 2021-06-07 | 2025-12-02 | 中国农业科学院作物科学研究所 | TaRomo1蛋白在调控小麦雄性育性中的应用 |
| WO2022270969A1 (ko) * | 2021-06-24 | 2022-12-29 | 한미약품 주식회사 | 비천연 5'-비번역 영역 및 3'-비번역 영역 및 그의 용도 |
| CN117999355A (zh) | 2021-08-24 | 2024-05-07 | 生物技术欧洲股份公司 | 体外转录技术 |
| KR20230083893A (ko) * | 2021-12-03 | 2023-06-12 | 고려대학교 산학협력단 | 번역 효율이 향상된 5'-utr, 이를 포함하는 합성 핵산 분자 및 이를 포함하는 백신 또는 치료제 조성물 |
| US12129223B2 (en) | 2021-12-16 | 2024-10-29 | Acuitas Therapeutics, Inc. | Lipids for use in lipid nanoparticle formulations |
| EP4469091A1 (en) | 2022-01-28 | 2024-12-04 | CureVac SE | Nucleic acid encoded transcription factor inhibitors |
| WO2023225360A2 (en) * | 2022-05-20 | 2023-11-23 | The University Of South Alabama | Capless and tailless therapeutic exogenous mrna and method to produce the same |
| US20250345407A1 (en) | 2022-05-25 | 2025-11-13 | CureVac SE | Nucleic acid based vaccine encoding an escherichia coli fimh antigenic polypeptide |
| CN119563026A (zh) * | 2022-07-19 | 2025-03-04 | 深圳深信生物科技有限公司 | 新型冠状病毒S蛋白的mRNA及其应用 |
| AU2023353931A1 (en) | 2022-09-26 | 2025-03-20 | Glaxosmithkline Biologicals Sa | Influenza virus vaccines |
| WO2024083345A1 (en) | 2022-10-21 | 2024-04-25 | BioNTech SE | Methods and uses associated with liquid compositions |
| US12186389B2 (en) | 2022-10-28 | 2025-01-07 | Glaxosmithkline Biologicals Sa | Nucleic acid base vaccine against emerging SARS-CoV-2 variants |
| WO2024098360A1 (zh) * | 2022-11-11 | 2024-05-16 | 斯微(上海)生物科技股份有限公司 | 人工核酸分子 |
| WO2024098361A1 (zh) * | 2022-11-11 | 2024-05-16 | 斯微(上海)生物科技股份有限公司 | 人工核酸分子 |
| NL2033707B1 (en) * | 2022-12-09 | 2024-06-14 | Stichting Sanquin Bloedvoorziening | Altering RNA sequences in non-coding regions for modification of protein expression |
| EP4658239A1 (en) | 2023-02-03 | 2025-12-10 | GlaxoSmithKline Biologicals S.A. | Rna formulation |
| GB202302092D0 (en) | 2023-02-14 | 2023-03-29 | Glaxosmithkline Biologicals Sa | Analytical method |
| CN118853659A (zh) * | 2023-04-14 | 2024-10-29 | 深圳瑞吉生物科技有限公司 | 提高mRNA翻译蛋白的输出量的核酸及其应用 |
| WO2024223728A1 (en) | 2023-04-27 | 2024-10-31 | Glaxosmithkline Biologicals Sa | Influenza virus vaccines |
| WO2024223724A1 (en) | 2023-04-27 | 2024-10-31 | Glaxosmithkline Biologicals Sa | Influenza virus vaccines |
| WO2024231621A1 (fr) | 2023-05-05 | 2024-11-14 | Centre National De La Recherche Scientifique | Acide nucleique synthetique et ses utilisations therapeutiques |
| WO2024230934A1 (en) | 2023-05-11 | 2024-11-14 | CureVac SE | Therapeutic nucleic acid for the treatment of ophthalmic diseases |
| WO2024260570A1 (en) | 2023-06-23 | 2024-12-26 | CureVac SE | Nucleic acid encoded antibodies |
| WO2025042847A1 (en) * | 2023-08-18 | 2025-02-27 | Dna Twopointo, Inc. | Plasmid-host systems |
| KR20250063952A (ko) * | 2023-10-30 | 2025-05-09 | 주식회사 녹십자 | 번역 효율이 향상된 3'-utr, 이를 포함하는 합성 핵산 분자 및 이를 포함하는 백신 또는 치료제 조성물 |
| WO2025132839A1 (en) | 2023-12-21 | 2025-06-26 | Glaxosmithkline Biologicals Sa | Influenza virus vaccines |
| GB202404607D0 (en) | 2024-03-29 | 2024-05-15 | Glaxosmithkline Biologicals Sa | RNA formulation |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013120629A1 (en) * | 2012-02-15 | 2013-08-22 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein |
| WO2013143700A2 (en) * | 2012-03-27 | 2013-10-03 | Curevac Gmbh | Artificial nucleic acid molecules comprising a 5'top utr |
| WO2013143698A1 (en) * | 2012-03-27 | 2013-10-03 | Curevac Gmbh | Artificial nucleic acid molecules |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| EP1800697B1 (de) | 2001-06-05 | 2010-04-14 | CureVac GmbH | Stabilisierte mRNA mit erhöhtem G/C-Gehalt für die Gentherapie |
| CA2632900A1 (en) * | 2005-12-12 | 2007-06-21 | Research Corporation Technologies, Inc. | Hybrid 3' untranslated regions suitable for efficient protein expression in mammalian cells |
| JP2009181427A (ja) * | 2008-01-31 | 2009-08-13 | Toshiba Corp | アクセス管理システム及びアクセス管理方法 |
| WO2010037408A1 (en) | 2008-09-30 | 2010-04-08 | Curevac Gmbh | Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| WO2012019630A1 (en) | 2010-08-13 | 2012-02-16 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein |
| RU2750261C2 (ru) * | 2012-03-27 | 2021-06-25 | Кьюрвак Аг | Искусственные молекулы нуклеиновых кислот для улучшенной экспрессии белков и пептидов |
| AU2014375402B2 (en) * | 2013-12-30 | 2020-10-01 | CureVac SE | Artificial nucleic acid molecules |
| JP6584414B2 (ja) * | 2013-12-30 | 2019-10-02 | キュアバック アーゲー | 人工核酸分子 |
-
2015
- 2015-12-29 CA CA2966092A patent/CA2966092A1/en active Pending
- 2015-12-29 BR BR112017009835A patent/BR112017009835A2/pt not_active Application Discontinuation
- 2015-12-29 EP EP15820544.3A patent/EP3240558A1/en not_active Withdrawn
- 2015-12-29 RU RU2017127203A patent/RU2757675C2/ru active
- 2015-12-29 EP EP19152916.3A patent/EP3494982A1/en active Pending
- 2015-12-29 CN CN201580070984.3A patent/CN107124889A/zh active Pending
- 2015-12-29 SG SG11201704681QA patent/SG11201704681QA/en unknown
- 2015-12-29 SG SG10201906673WA patent/SG10201906673WA/en unknown
- 2015-12-29 WO PCT/EP2015/081366 patent/WO2016107877A1/en not_active Ceased
- 2015-12-29 AU AU2015373404A patent/AU2015373404B2/en active Active
- 2015-12-29 MX MX2017008670A patent/MX2017008670A/es unknown
- 2015-12-29 KR KR1020177021407A patent/KR102580696B1/ko active Active
- 2015-12-29 JP JP2017534943A patent/JP6907116B2/ja active Active
- 2015-12-29 US US15/540,610 patent/US20180148727A1/en not_active Abandoned
-
2019
- 2019-07-26 US US16/523,214 patent/US20190345504A1/en not_active Abandoned
-
2021
- 2021-06-30 JP JP2021108273A patent/JP2021168664A/ja active Pending
-
2024
- 2024-01-17 US US18/415,477 patent/US20240294928A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013120629A1 (en) * | 2012-02-15 | 2013-08-22 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein |
| WO2013143700A2 (en) * | 2012-03-27 | 2013-10-03 | Curevac Gmbh | Artificial nucleic acid molecules comprising a 5'top utr |
| WO2013143698A1 (en) * | 2012-03-27 | 2013-10-03 | Curevac Gmbh | Artificial nucleic acid molecules |
Non-Patent Citations (1)
| Title |
|---|
| WEINSTEIN L.S. et al., Minireview: GNAS: Normal and Abnormal Functions, Endocrinology, 2004, Vol.145, N12, pp.5459-5464. * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102580696B1 (ko) | 2023-09-19 |
| AU2015373404B2 (en) | 2021-09-09 |
| JP6907116B2 (ja) | 2021-07-21 |
| EP3240558A1 (en) | 2017-11-08 |
| WO2016107877A1 (en) | 2016-07-07 |
| BR112017009835A2 (pt) | 2017-12-26 |
| RU2017127203A (ru) | 2019-02-01 |
| CA2966092A1 (en) | 2016-07-07 |
| AU2015373404A1 (en) | 2017-05-25 |
| EP3494982A1 (en) | 2019-06-12 |
| SG10201906673WA (en) | 2019-09-27 |
| RU2017127203A3 (OSRAM) | 2020-01-10 |
| CN107124889A (zh) | 2017-09-01 |
| US20240294928A1 (en) | 2024-09-05 |
| US20180148727A1 (en) | 2018-05-31 |
| JP2018501802A (ja) | 2018-01-25 |
| KR20170100660A (ko) | 2017-09-04 |
| JP2021168664A (ja) | 2021-10-28 |
| MX2017008670A (es) | 2017-10-11 |
| US20190345504A1 (en) | 2019-11-14 |
| SG11201704681QA (en) | 2017-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2757675C2 (ru) | Молекулы новых искусственных нуклеиновых кислот | |
| RU2717986C2 (ru) | Искусственные молекулы нуклеиновой кислоты | |
| JP7245878B2 (ja) | 人工核酸分子 | |
| JP6584414B2 (ja) | 人工核酸分子 | |
| JP6648019B2 (ja) | Ｒｎａコードされたタンパク質の発現を促進するための医薬的組成物、医薬的組成物の製造のための修飾ｒｎａの使用、および、医薬的組成物を含むパーツキット | |
| RU2774415C1 (ru) | Искусственные молекулы нуклеиновой кислоты | |
| RU2772349C2 (ru) | Искусственные молекулы нуклеиновой кислоты | |
| HK40068167A (en) | Artificial nucleic acid molecules | |
| BR112018001995B1 (pt) | Molécula de ácido nucleico artificial, vetor, composição farmacêutica, método para aumentar a eficiência de tradução de uma molécula de ácido nucleico artificial, uso in vitro de um elemento 3´-utr e kit |